Sir, The Rhesus (Rh) system is one of the most complex blood group systems in humans. The Rhesus D (RhD) antigen is the most important antigen because of its immunogenicity. The weak D antigen is a RhD phenotype which expresses lesser numbers of the complete D antigen on the surface of the red cells.
The study was conducted in regional blood transfusion center, Lady Hardinge Medical College. The prevalence of weak D among all RhD-negative cases coming to blood bank (donors as well as recipients) was assessed from January 2013 to June 2015. All the cases which tested negative for RhD antigen in routine blood grouping were subjected to weak D testing. For testing, identification (ID)-Diaclon anti-D containing monoclonal anti-D IgG was used, and the test was performed in ID-card low ionic strength solution/Coombs (containing polyspecific antihuman globulin). As false-positive results may occur in cases with a positive direct Coombs test (DCT), DCT was performed in all cases which tested positive with weak D reagent.
A total of 1149 RhD antigen-negative cases were documented in the blood bank for the period mentioned. Out of these, 15 cases tested positive with weak D reagent. DCT of these cases was performed as a protocol and was found positive in 4 cases. Therefore, only 11 cases were true positive. Therefore, the incidence of weak D was 0.96% in the Rh-negative population.
The Rh gene lies on chromosome one and the locus is composed of 2 highly homologous genes: the RhD gene encoding for the D protein and the RHCE gene encoding for the C, c, E, and e proteins. [1, 2] There are 6 alleles but only 5 antigens since D is an amorph gene. [3] Among these, D is the most immunogenic and D is often called the Rh antigen. The terms Rh+ and Rh-refer to the presence or absence of D antigen.
RhD antigen consists of different epitopic structures distributed along the extracellular portions of the RhD protein. [4] Variant forms of the D antigen occur due to changes in the amino acid sequence of the RhD which do not abate the entire D antigen but cause epitope loss. 
A Pilot Study Analysis of Transfusion-related Adverse Events at the Tertiary Care Hospital in Eastern India: Encourages the Establishment of Institutional Hemovigilance Program
volume of blood transfused was 145 ml. Among these reactions, the most common were febrile nonhemolytic reactions (FNHTR) (75%), followed by allergic reactions (25%). The risk of adverse reaction was calculated per 1000 transfusions of that component, i.e., (total number of implicated reactions/total number of components transfused) × 1000. The estimated risk for FNHTR following red cell transfusions is 3.2, while that for allergic reaction is 1.07/1000 red cell transfusions. The overall frequency of transfusion reactions was 0.3% (4 out of 1313 units). Our study found higher frequency of transfusion reactions (0.3%) than the studies in other tertiary care institutions, which shows the frequency of transfusion reactions from 0.05% to 0.18%. [2, 3] The higher value in this study could be due to the small duration of study and the small study population. The estimated risk of FNHTRs was 3.2/1000 red cell transfusions (3/932 PRBC units). A study by Vasudev et al. [4] revealed estimated risk 0.8/1000 transfusions and that by Kumar et al. [2] showed 0.04%. The relatively higher value in this study could Sir, We conducted a study on transfusion-related adverse reactions under the support of the Indian Council of Medical Research short-term student project at our institute. This prospective and observational study was conducted after obtaining clearance from the institutional ethics committee for 6 months (May 2016 to October 2016, and compared to the reporting of previous 6 months) to detect and analyze the spectrum of Adverse Transfusion Reactions (ATR) and to establish an institutional hemovigilance program with the main goal to improve transfusion safety. Blood transfusion is a life-saving measure, but it has its inherent risks. [1] The evaluation of transfusion reaction broadly included clerical checks, clinical evaluation, visual inspection, investigations in the department of transfusion medicine (blood grouping, cross-matching, direct and indirect Coombs test, antibody screening, and identification); a few special investigations such as urine for hemoglobinuria, plasma hemoglobin, peripheral blood smear for schistocytes and spherocytes, serum lactate dehydrogenase, unconjugated bilirubin to rule out hemolytic reaction and some other relevant investigations such as chest X-ray and bacteriological culture to rule out any possibility of nonhemolytic reactions, especially bacterial sepsis and transfusion-related acute lung injury. During the study, a total of 1313 units of blood and blood components (packed red blood cell [PRBC] 932 units, whole blood 210 units, fresh frozen plasma 118 units, and platelet concentrate 53 units) were transfused to 778 patients. The median age of the study population was 48 years. Four patients developed ATRs to PRBC transfusion [ Table 1 ]. The mean
